CCF Webinar: Rilvegostomig + Chemo Trial (ARTEMIDE-Biliary02) in Advanced BTC

Patients with newly diagnosed advanced biliary tract cancer are often treated with immunotherapy plus chemotherapy. This webinar will discuss a new ongoing clinical trial in biliary tract cancer investigating a new immunotherapy drug called rilvegostomig in combination with standard chemotherapy. The study called ARTEMIDE-Biliary02 is a phase III randomized global study of rilvegostomig or durvalumab in combination with chemotherapy in first-line treatment of advanced biliary tract cancer. Sponsored by AstraZeneca Recorded on June 16, 2026

Join Today
AC26 - Patient Perspective - Moving Faster than CCA: Fighting the System & Cancer, Keaton Herzer
▶︎

AC26 - Patient Perspective - Moving Faster than CCA: Fighting the System & Cancer, Keaton Herzer

Ivermectin to Treat Cancer? Get the FACTS
▶︎

Ivermectin to Treat Cancer? Get the FACTS

AC26 - Keynote: Research in CCA: Accomplishments, Advances, & Aspirations, Gregory Gores
▶︎

AC26 - Keynote: Research in CCA: Accomplishments, Advances, & Aspirations, Gregory Gores

The Complete Cardiology Masterclass: Exam-Ready in One Video
▶︎

The Complete Cardiology Masterclass: Exam-Ready in One Video

AC26 - Looking Down the Pipeline, Anthony El-Khoueiry
▶︎

AC26 - Looking Down the Pipeline, Anthony El-Khoueiry

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎

AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD

AC26 - AI vs. Clinical Experience: Who Will Lead the Future of Cholangiocarcinoma Care? Milind Javle
▶︎

AC26 - AI vs. Clinical Experience: Who Will Lead the Future of Cholangiocarcinoma Care? Milind Javle

Learn From Proficiency: Here’s How Today’s Market Wizards Made Their Fortunes | Investing With IBD
▶︎

Learn From Proficiency: Here’s How Today’s Market Wizards Made Their Fortunes | Investing With IBD

Politics Chat, June 18, 2026
▶︎

Politics Chat, June 18, 2026

AC26 - Hepatic Arterial Infusion Pump for iCCA: Improving Survival & Quality of Life, Skye Mayo
▶︎

AC26 - Hepatic Arterial Infusion Pump for iCCA: Improving Survival & Quality of Life, Skye Mayo

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source
▶︎

RL for Agents Workshop - Deep Dive on Training Agents with RL and Open Source

Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li
▶︎

Seniors No 1 Oncologist Reveals Foods to Starve Cancer Cells Naturally After 50! |Dr. William Li

AC26 - Multidisciplinary Tumor Board
▶︎

AC26 - Multidisciplinary Tumor Board

Ancient Human Species We Once Co-Existed With
▶︎

Ancient Human Species We Once Co-Existed With

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]
▶︎

Microsoft Fabric and Power BI - Developer of the Future⚡ [Full Course]

AC26 - Keynote: Beyond Immune Checkpoint Blockade: Emerging Strategies, Tak Mak
▶︎

AC26 - Keynote: Beyond Immune Checkpoint Blockade: Emerging Strategies, Tak Mak

Antineoplastic Agents | Clinical Medicine
▶︎

Antineoplastic Agents | Clinical Medicine

Stocks Jump As Trump Touts Iran Deal: SiTime, Krystal Biotech, Howmet In Focus | Stock Market Today
▶︎

Stocks Jump As Trump Touts Iran Deal: SiTime, Krystal Biotech, Howmet In Focus | Stock Market Today

AC26 - Clinical Progress in Cholangiocarcinoma: Review of Key Industry Abstracts, Mark Yarchoan
▶︎

AC26 - Clinical Progress in Cholangiocarcinoma: Review of Key Industry Abstracts, Mark Yarchoan